NOTE: As provided in LFC policy, this report is
intended only for use by the standing finance committees of the
legislature. The Legislative Finance Committee does not assume
responsibility for the accuracy of the information in this report when used for
other purposes.
The most recent FIR
version (in HTML & Adobe PDF formats) is available on the Legislative
Website. The Adobe PDF version includes
all attachments, whereas the HTML version does not. Previously issued FIRs and attachments may be
obtained from the LFC in
SPONSOR: |
HCPAC |
DATE TYPED: |
|
HB |
605/HCPACS/aHBIC |
||
SHORT TITLE: |
Prescription Drug ID Cards |
SB |
|
||||
|
ANALYST: |
|
|||||
APPROPRIATION
Appropriation
Contained |
Estimated
Additional Impact |
Recurring or
Non-Rec |
Fund Affected |
||
FY03 |
FY04 |
FY03 |
FY04 |
|
|
|
|
|
See Narrative |
|
|
Relates to SB160, SB555
and HB513
Responses
Received From
Public
School Insurance Authority (PSIA)
Public
Regulation Commission (PRC)
Retiree
Health Care Authority (RHCA)
Health
Policy Commission (HPC)
Department
of Health (DOH)
Human
Services Department (HSD)
SUMMARY
Synopsis of HBIC Amendment
The House Business and Industry Committee
amendment removes the requirement that a uniform prescription drug information
card must conform to the format of the National Council for Prescription Drug
Programs' current implementation guide for such cards. The amendment also
deletes the requirement for the uniform prescription drug information card to
have the name and address of the benefits administrator or other entity
responsible for prescription claims submission, adjudication or pharmacy
provider correspondence for prescription benefits claims.
The HBIC amendment clarifies that the
Prescription Drug Uniform Information Card Act shall not apply to the medicaid fee-for-service prescription drug program.
Synopsis of Original Bill
The House Consumer
& Public Affairs Committee substitute for House Bill 605 requires a health benefit plan
providing prescription drug coverage and issuing a prescription drug
card for claims submission, to issue a uniform prescription drug information
card conforming to the standards and format of the national council for prescription
drug programs’ current implementation guide. This bill applies to
fully insured and self-insured programs.
HB 605/HCPACS sets forth minimum standard
information to be contained in uniform prescription drug information cards
based on the current standards and formats of the National Council for
Prescription Drug Program’s (NCPDP) implementation guide.
HB 605/HCPACS requires a health benefit plan or third party administrator to issue the uniform card upon enrollment and reissue the uniform card within a reasonable time of any change. A new card will not have to be issued more often than once a year and plans have the option of using stickers to temporarily update cards until uniform cards are reissued.
The minimum
information that must be included on the card:
Significant
Issues
Proponents of House Bill 605/HCPACS believe pharmacists currently spend too much time with the administrative processing and paperwork between patients and the numerous and diverse private and public prescription drug coverage programs. This situation is further complicated by the increase in prescriptions and the decrease in pharmacists. As such, proponents argue that a uniform prescription drug identification card would help improve the quality care to patients, and reduce unnecessary administrative burdens on practicing pharmacists, and help the public and private insurance industries realize efficiencies associated with uniformity and standardization.
Opponents of HB 605/HCPACS argue that the design
of a uniform drug identification card should be practical, flexible and not
impose unnecessary financial burdens on insurers. However, HB 605/HCPAC calls for a uniform
drug identification card containing standard necessary information based on the
NCPDP’s guidelines.
HB 605/HCPAC supports the recommendations of the
HPC’s Prescription Drug Study Advisory Committee, which suggested creative
methods be used to reduce the amount of administrative responsibilities
pharmacists have to process the numerous types of public and private insurance
discount programs. Studies show 68% of a pharmacist’s
time is spent on non-patient related issues. The committee members suggested pharmacists’
time would be better spent counseling and educating their consumers on
medication issues.
HSD states that as the single state Medicaid
agency for the state of New Mexico, pursuant to 42 USC 1396a, and 42 CFR §
431.10, it may not be subjected to another agency’s authority. House Bill
605/HCPAC would subject HSD to the authority of the Superintendent of
Insurance, in contravention of its agreement with the federal government. This
would be made worse if the “guidelines” allow a pharmacist to refuse service to
a Medicaid client who does not, or cannot, produce the card when filing a
prescription.
FISCAL IMPLICATIONS
The PSIA notes the
printing of the new cards and mailing to all PSIA members will result in more expense
to the plan and more phone calls from members. The PSIA covers approximately
58,000 members, and new cards will need to be mailed to the employee’s home
address. The cost of the printing and
mailing is estimated at $10,000 to $15,000.
There is no appropriation contained in the bill and this expense is not
anticipated. There will be a similar impact
on the RHCA and the General Services Department.
If timed correctly, however, the ID cards could be mailed out on the fiscal year boundaries since this is often done anyway, and the health plans could avoid additional expense.
ADMINISTRATIVE IMPLICATIONS
HB 605/HCPACS
authorizes the Superintendent of Insurance, if he deems it necessary, to draft
and adopt regulations by
RELATIONSHIP
Relates to:
SB160, Prescription
Drug Programs
SB555, Prescription
Drug Co-Payment Standards
HB513, Senior
Prescription Drug Program Efficiency
OTHER SUBSTANTIVE ISSUES
Each individual or
group health insurance policy, plan or certificate currently issues individual
and unique identification cards for eligible members. These cards vary in their usefulness for
billing purposes when presented by patients when obtaining their prescription
drugs. Some providing adequate
information, others less than minimal and some cards only contain the name of
the patient and the company. This requires pharmacy staff to contact the
company for additional information including current patient coverage and
eligibility and to ascertain whether the prescribed drug is also covered. There
are national efforts to establish uniform prescription drug identification
cards to improve retail pharmacy administrative efficiencies.
Issuance of a
universal uniform prescription drug identification card would eliminate a vast
majority of rejects based on inaccurate patient information. Instructions for use for a particular card
are voluminous and are different for each card, requiring providers to spend
valuable time researching correct patient information, time that could be
utilized in patient care or prescription filling. In addition, there could be
potential cost savings through identification of alternate payer sources and
potential service duplication.
DW/yr